Floatz logo

Depocyte®

Adult Acute Lymphocytic Leukemia

Goethe UniversitySmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
81/ 100

Competitive context

74 Active assets in the Adult Acute Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
MERCAPTOPURINE ANHYDROUS
Shanxi Bethune Hospital
Phase 4A
Cyclophosphamide
The First Affiliated Hospital of Zhengzhou University
Phase 4BBB
Cytosin-Arabinosid
PETHEMA Foundation
Phase 4BBB
METHOTREXATE
PETHEMA Foundation
Phase 4BBB
DEXAMETHASONE
Shanxi Bethune Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Depocyte® is also rated in:

acute lymphoblastic leukemiaDormant
B
Indicative ·
56 / 100
View asset →
lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →
neoplastic meningitisDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →